Conditions: Dry Eye Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 711
Healthy volunteers: no

Brief summary:
Evaluate the efficacy and safety of Lifitegrast in subjects with dry eye disease and a recent history of artificial tear use.

Detailed description:

Arms:
arm 1: Lifitegrast Ophthalmic Solution 5%, BID for 84 days arm 2: Placebo to match active treatment, BID for 84 days

Interventions: intervention 1: Lifitegrast intervention 2: Placebo
Intervention descriptions: intervention 1: Lifitegrast Ophthalmic Solution 5%, BID for 84 days intervention 2: Placebo to match active treatment, BID for 84 days

Protocol document: